Protocol detail

Evaluation of Anticancer Compounds

Find Similar Protocols

Veliparib was provided by AbbVie. Etoposide, GSK461364, ABT-263, DMXAA and C178 were purchased from Cayman Chemical.

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Liu Y., Pagacz J., Wolfgeher D.J., Bromerg K.D., Gorman J.V, & Kron S.J. (2023). Senescent cancer cell vaccines induce cytotoxic T cell responses targeting primary tumors and disseminated tumor cells. Journal for Immunotherapy of Cancer, 11(2), e005862.

Publication 2023

Veliparib Etoposide GSK461364 ABT-263 DMXAA

Abt 263 Cayman Dmxaa Etoposide Gsk461364 Veliparib

Top 5 similar protocols

Variable analysis

independent variables

Veliparib
Etoposide
GSK461364
ABT-263
DMXAA

dependent variables

Unspecified

control variables

Unspecified

controls

Positive controls: Unspecified
Negative controls: Unspecified

Annotations

This protocol is too short. Unable to provide accurate annotations

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!